Literature DB >> 21482826

HIV-1 p17 matrix protein interacts with heparan sulfate side chain of CD44v3, syndecan-2, and syndecan-4 proteoglycans expressed on human activated CD4+ T cells affecting tumor necrosis factor alpha and interleukin 2 production.

Maria A De Francesco1, Manuela Baronio, Claudio Poiesi.   

Abstract

HIV-1 p17 contains C- and N-terminal sequences with positively charged residues and a consensus cluster for heparin binding. We have previously demonstrated by affinity chromatography that HIV-1 p17 binds strongly to heparin-agarose at physiological pH and to human activated CD4(+) T cells. In this study we demonstrated that the viral protein binds to heparan sulfate side chains of syndecan-2, syndecan-4, and CD44v3 purified from HeLa cells and that these heparan sulfate proteoglycans (HSPGs) co-localize with HIV-1 p17 on activated human CD4(+) T cells by confocal fluorescence analysis. Moreover, we observed a stimulatory or inhibitory activity when CD4(+) T cells were activated with mitogens together with nanomolar or micromolar concentrations of the matrix protein.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21482826      PMCID: PMC3103333          DOI: 10.1074/jbc.M110.191270

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Constitutive intracellular expression and activation-induced cell surface up-regulation of CD44v3 in human T lymphocytes.

Authors:  C Forster-Horváth; J Bocsi; E Rásó; T I Orbán; E Olah; J Tímár; A Ladányi
Journal:  Eur J Immunol       Date:  2001-02       Impact factor: 5.532

Review 2.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

3.  Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function.

Authors:  L Teixeira; H Valdez; J M McCune; R A Koup; A D Badley; M K Hellerstein; L A Napolitano; D C Douek; G Mbisa; S Deeks; J M Harris; J D Barbour; B H Gross; I R Francis; R Halvorsen; R Asaad; M M Lederman
Journal:  AIDS       Date:  2001-09-28       Impact factor: 4.177

Review 4.  Viral late domains.

Authors:  Eric O Freed
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

5.  Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients.

Authors:  R A Lempicki; J A Kovacs; M W Baseler; J W Adelsberger; R L Dewar; V Natarajan; M C Bosche; J A Metcalf; R A Stevens; L A Lambert; W G Alvord; M A Polis; R T Davey; D S Dimitrov; H C Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

6.  HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor.

Authors:  Maria A De Francesco; Manuela Baronio; Simona Fiorentini; Costantino Signorini; Carlo Bonfanti; Claudio Poiesi; Mikulas Popovic; Manuela Grassi; Emirena Garrafa; Luisa Bozzo; George K Lewis; Stefano Licenziati; Robert C Gallo; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-08       Impact factor: 11.205

7.  Evidence for increased T cell turnover and decreased thymic output in HIV infection.

Authors:  D C Douek; M R Betts; B J Hill; S J Little; R Lempicki; J A Metcalf; J Casazza; C Yoder; J W Adelsberger; R A Stevens; M W Baseler; P Keiser; D D Richman; R T Davey; R A Koup
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

8.  Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy.

Authors:  Mikulas Popovic; Klara Tenner-Racz; Colleen Pelser; Hans-Jurgen Stellbrink; Jan van Lunzen; George Lewis; Vaniambadi S Kalyanaraman; Robert C Gallo; Paul Racz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

9.  Interaction of the CC-chemokine RANTES with glycosaminoglycans activates a p44/p42 mitogen-activated protein kinase-dependent signaling pathway and enhances human immunodeficiency virus type 1 infectivity.

Authors:  Theresa Li-Yun Chang; Cynthia J Gordon; Branka Roscic-Mrkic; Christine Power; Amanda E I Proudfoot; John P Moore; Alexandra Trkola
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

10.  Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.

Authors:  J A Kovacs; R A Lempicki; I A Sidorov; J W Adelsberger; B Herpin; J A Metcalf; I Sereti; M A Polis; R T Davey; J Tavel; J Falloon; R Stevens; L Lambert; R Dewar; D J Schwartzentruber; M R Anver; M W Baseler; H Masur; D S Dimitrov; H C Lane
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307

View more
  12 in total

Review 1.  Role of heparan sulfate in sexually transmitted infections.

Authors:  Vaibhav Tiwari; Erika Maus; Ira M Sigar; Kyle H Ramsey; Deepak Shukla
Journal:  Glycobiology       Date:  2012-07-06       Impact factor: 4.313

2.  Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists.

Authors:  Antonella Bugatti; Cinzia Giagulli; Chiara Urbinati; Francesca Caccuri; Paola Chiodelli; Pasqua Oreste; Simona Fiorentini; Alessandro Orro; Luciano Milanesi; Pasqualina D'Ursi; Arnaldo Caruso; Marco Rusnati
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

3.  HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.

Authors:  Francesca Caccuri; Cinzia Giagulli; Antonella Bugatti; Anna Benetti; Giulio Alessandri; Domenico Ribatti; Stefania Marsico; Paola Apostoli; Mark A Slevin; Marco Rusnati; Carlos A Guzman; Simona Fiorentini; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-17       Impact factor: 11.205

4.  The HIV matrix protein p17 subverts nuclear receptors expression and induces a STAT1-dependent proinflammatory phenotype in monocytes.

Authors:  Barbara Renga; Daniela Francisci; Claudio D'Amore; Elisabetta Schiaroli; Andrea Mencarelli; Sabrina Cipriani; Franco Baldelli; Stefano Fiorucci
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

5.  The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma.

Authors:  Barbara Renga; Daniela Francisci; Adriana Carino; Silvia Marchianò; Sabrina Cipriani; Maria Chiara Monti; Rachele Del Sordo; Elisabetta Schiaroli; Eleonora Distrutti; Franco Baldelli; Stefano Fiorucci
Journal:  Sci Rep       Date:  2015-10-15       Impact factor: 4.379

6.  HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders.

Authors:  Yasmin Zeinolabediny; Francesca Caccuri; Laura Colombo; Federica Morelli; Margherita Romeo; Alessandro Rossi; Silvia Schiarea; Carlotta Ciaramelli; Cristina Airoldi; Ria Weston; Liu Donghui; Jerzy Krupinski; Rubén Corpas; Elisa García-Lara; Sara Sarroca; Coral Sanfeliu; Mark Slevin; Arnaldo Caruso; Mario Salmona; Luisa Diomede
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

Review 7.  Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.

Authors:  Paola Chiodelli; Antonella Bugatti; Chiara Urbinati; Marco Rusnati
Journal:  Molecules       Date:  2015-04-10       Impact factor: 4.411

Review 8.  Diversity of heparan sulfate and HSV entry: basic understanding and treatment strategies.

Authors:  Vaibhav Tiwari; Morgan S Tarbutton; Deepak Shukla
Journal:  Molecules       Date:  2015-02-05       Impact factor: 4.411

9.  TLR10 Senses HIV-1 Proteins and Significantly Enhances HIV-1 Infection.

Authors:  Bethany M Henrick; Xiao-Dan Yao; Muhammad Atif Zahoor; Alash'le Abimiku; Sophia Osawe; Kenneth L Rosenthal
Journal:  Front Immunol       Date:  2019-03-15       Impact factor: 7.561

10.  The HIV matrix protein p17 promotes the activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2.

Authors:  Barbara Renga; Daniela Francisci; Elisabetta Schiaroli; Adriana Carino; Sabrina Cipriani; Claudio D'Amore; Angelo Sidoni; Rachele Del Sordo; Ivana Ferri; Monica Lucattelli; Benedetta Lunghi; Franco Baldelli; Stefano Fiorucci
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.